Ligne de temps
Ingrid Fert
Ingénieur(e) de Recherche
07 sept. 2023
publication
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Lire plus18 avr. 2023
publication
Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication.
Lire plus21 déc. 2022
publication
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Lire plus14 sept. 2022
publication
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Lire plus27 avr. 2022
publication
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Lire plus07 déc. 2021
publication
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Lire plus29 juil. 2021
01 janv. 2021
publication
Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study.
Lire plus16 juil. 2015